201 related articles for article (PubMed ID: 24023648)
1. Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats.
Badole SL; Chaudhari SM; Bagul PP; Mahamuni SP; Khose RD; Joshi AC; Raut CG; Zanwar AA
PLoS One; 2013; 8(8):e72817. PubMed ID: 24023648
[TBL] [Abstract][Full Text] [Related]
2. Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.
Badole SL; Mahamuni SP; Bagul PP; Khose RD; Joshi AC; Ghule AE; Bodhankar SL; Raut CG; Khedkar VM; Coutinho EC; Wagh NK
Eur J Pharmacol; 2013 Jan; 698(1-3):470-9. PubMed ID: 23117087
[TBL] [Abstract][Full Text] [Related]
3. Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
Badole SL; Bagul PP; Mahamuni SP; Khose RD; Joshi AC; Jangam GB; Ghule AE; Raut CG; Khedkar VM; Coutinho EC
Chem Biol Interact; 2013 Apr; 203(2):530-41. PubMed ID: 23466488
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic activity of cycloart-23-ene-3beta, 25-diol (B2) isolated from Pongamia pinnata (L. Pierre) in streptozotocin-nicotinamide induced diabetic mice.
Badole SL; Bodhankar SL
Eur J Pharmacol; 2010 Apr; 632(1-3):103-9. PubMed ID: 20122920
[TBL] [Abstract][Full Text] [Related]
5. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.
Samocha-Bonet D; Wong O; Synnott EL; Piyaratna N; Douglas A; Gribble FM; Holst JJ; Chisholm DJ; Greenfield JR
J Nutr; 2011 Jul; 141(7):1233-8. PubMed ID: 21593352
[TBL] [Abstract][Full Text] [Related]
6. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
Sangle GV; Lauffer LM; Grieco A; Trivedi S; Iakoubov R; Brubaker PL
Endocrinology; 2012 Feb; 153(2):564-73. PubMed ID: 22186413
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin.
Manaer T; Yu L; Zhang Y; Xiao XJ; Nabi XH
J Ethnopharmacol; 2015 Jul; 169():269-74. PubMed ID: 25922265
[TBL] [Abstract][Full Text] [Related]
8. Combination of mangiferin and dipeptidyl peptidase-4 inhibitor sitagliptin improves impaired glucose tolerance in streptozotocin-diabetic rats.
Hou J; Zheng D; Fan K; Yu B; Xiao W; Ma J; Jin W; Tan Y; Wu J
Pharmacology; 2012; 90(3-4):177-82. PubMed ID: 22948814
[TBL] [Abstract][Full Text] [Related]
9. "2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acid" a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: Plausible role of inflammatory and oxidative stress markers.
Paudel YN; Ali MR; Adil M; Bawa S; Sharma M
Biomed Pharmacother; 2017 Nov; 95():1232-1241. PubMed ID: 28938514
[TBL] [Abstract][Full Text] [Related]
10. Alleviation of diabetes mellitus through the restoration of β-cell function and lipid metabolism by Aloe vera (L.) Burm. f. extract in obesogenic WNIN/GR-Ob rats.
Deora N; Sunitha MM; Satyavani M; Harishankar N; Vijayalakshmi MA; Venkataraman K; Venkateshan V
J Ethnopharmacol; 2021 May; 272():113921. PubMed ID: 33588009
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes.
Mu J; Petrov A; Eiermann GJ; Woods J; Zhou YP; Li Z; Zycband E; Feng Y; Zhu L; Roy RS; Howard AD; Li C; Thornberry NA; Zhang BB
Eur J Pharmacol; 2009 Nov; 623(1-3):148-54. PubMed ID: 19765579
[TBL] [Abstract][Full Text] [Related]
12. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
[TBL] [Abstract][Full Text] [Related]
13. Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat).
Ferreira L; Teixeira-de-Lemos E; Pinto F; Parada B; Mega C; Vala H; Pinto R; Garrido P; Sereno J; Fernandes R; Santos P; Velada I; Melo A; Nunes S; Teixeira F; Reis F
Mediators Inflamm; 2010; 2010():592760. PubMed ID: 20652060
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Kishimoto M; Noda M
Cardiovasc Diabetol; 2011 Dec; 10():115. PubMed ID: 22189184
[TBL] [Abstract][Full Text] [Related]
15. Rhinacanthin C ameliorates hyperglycaemia, hyperlipidemia and pancreatic destruction in streptozotocin-nicotinamide induced adult male diabetic rats.
Adam SH; Giribabu N; Rao PV; Sayem AS; Arya A; Panichayupakaranant P; Korla PK; Salleh N
Eur J Pharmacol; 2016 Jan; 771():173-90. PubMed ID: 26703866
[TBL] [Abstract][Full Text] [Related]
16. Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Pharmacol Rep; 2009; 61(5):899-908. PubMed ID: 19904014
[TBL] [Abstract][Full Text] [Related]
17. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
[TBL] [Abstract][Full Text] [Related]
18. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats.
Yu YL; Lu SS; Yu S; Liu YC; Wang P; Xie L; Wang GJ; Liu XD
J Ethnopharmacol; 2009 Jul; 124(3):444-9. PubMed ID: 19497359
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of aqueous seed extract of Vitis Vinifera against oxidative stress, inflammation and apoptosis in the pancreas of adult male rats with diabetes mellitus.
Adam SH; Giribabu N; Kassim N; Kumar KE; Brahmayya M; Arya A; Salleh N
Biomed Pharmacother; 2016 Jul; 81():439-452. PubMed ID: 27261624
[TBL] [Abstract][Full Text] [Related]
20. Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Garg SK; Moser EG; Bode BW; Klaff LJ; Hiatt WR; Beatson C; Snell-Bergeon JK
Endocr Pract; 2013; 19(1):19-28. PubMed ID: 23186950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
